Purdue Pharma L.P. et al v. Acura Pharmaceuticals Inc. et al

Justia Dockets & Filings Third Circuit Delaware District Court Purdue Pharma L.P. et al v. Acura Pharmaceuticals Inc. et al

Purdue Pharma L.P. et al v. Acura Pharmaceuticals Inc. et al

Plaintiff:	PF Laboratories Inc., Purdue Pharma LP and Purdue Pharmaceuticals LP
Defendant:	Acura Pharmaceuticals Inc., Egalet Corporation and Egalet US Inc.
Case Number:	1:2015cv00292
Filed:	April 3, 2015
Court:	US District Court for the District of Delaware
Office:	Wilmington Office
County:	New Castle
Presiding Judge:	Richard G Andrews
Nature of Suit:	Patent
Cause of Action:	35 U.S.C. § 271 Patent Infringement
Jury Demanded By:	Plaintiff

RSS Track this Docket

Docket Report

This docket was last retrieved on May 24, 2016. A more recent docket listing may be available from PACER.

Date Filed	Document Text
May 24, 2016	Filing 64 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,389,007 B2. (Attachments: #1 Order)(nms)
May 24, 2016	Filing 63 ORDER Denying #61 Joint MOTION to Vacate, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 5/24/2016. (nms)
May 24, 2016	Filing 62 SO ORDERED Granting #60 Joint Stipulation of Dismissal, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 5/24/2016. (nms)
May 24, 2016	Filing 61 Joint MOTION to Vacate - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit A)(Castellano, Jeffrey) Modified on 5/24/2016 (nms).
May 24, 2016	Filing 60 Joint Stipulation of Dismissal, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey) Modified on 5/24/2016 (nms).
May 4, 2016	Filing 59 STIPULATION TO EXTEND TIME to EXTEND the deadline to Substantially Complete Document Production to 6/3/2016 - filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
May 4, 2016	Filing 58 ORAL ORDER: The mediation scheduled for 5/16/16 at 10:00 AM with Judge Thynge is cancelled. Signed by Judge Mary Pat Thynge on 5/4/16. (cak)
May 4, 2016	SO ORDERED, re #59 STIPULATION TO EXTEND TIME to EXTEND the deadline to Substantially Complete Document Production to 6/3/2016, filed by Egalet US Inc., Egalet Corporation, Acura Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/4/2016. (nms)
March 30, 2016	Filing 57 NOTICE OF SERVICE of Defendants' Responses to Purdue's First Set of Interrogatories filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc..(Farnan, Brian)
March 14, 2016	SO ORDERED, re #56 Stipulation and Order Extending Case Schedule (see Stipulation for further details). Signed by Judge Richard G. Andrews on 3/14/2016. (nms)
March 11, 2016	Filing 56 STIPULATION to Amend Scheduling Order by Acura Pharmaceuticals Inc.. (Farnan, Brian)
March 8, 2016	SO ORDERED, re #55 STIPULATION TO EXTEND TIME Deadline for Substantial Completion of Document Production to April 18, 2016, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 3/7/2016. (nms)
March 7, 2016	Filing 55 STIPULATION TO EXTEND TIME (Deadline for Substantial Completion of Document Production) to April 18, 2016 - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey)
February 12, 2016	Filing 54 NOTICE OF SERVICE of (1) Purdue's Responses and Objections to Defendants' Second Set of Requests for Production (Nos. 4-76) (2) Purdue's First Set of Interrogatories (3) Plaintiffs' Responses and Objections to Defendants' Second Set of Interrogatories filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
February 12, 2016	Filing 53 NOTICE OF SERVICE of Defendants' Responses to Purdue's Second Set of Requests for Production of Documents and Things filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc..(Farnan, Michael)
February 8, 2016	Filing 52 ORDER Setting Mediation Conferences: A Mediation Conference is set for 5/16/2016 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Ordered by Judge Mary Pat Thynge on 2/8/16. (cak)
January 25, 2016	Filing 51 ORDER Construing the "Polyvinylpyrrolidone" Term of U.S> Patent No. 8,389,007. Signed by Judge Richard G. Andrews on 1/25/2016. (nms)
January 22, 2016	Filing 50 PROPOSED ORDER Construing the Polyvinylpyrrolidone Term of U.S. Patent No. 8,389,007, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey) Modified on 1/25/2016 (nms).
January 20, 2016	Filing 49 STIPULATION TO EXTEND TIME [Substantial Completion of Document Production and Fact Discovery Cutoff] to March 16, 2016 and July 14, 2016 - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey)
January 20, 2016	SO ORDERED, re #49 STIPULATION TO EXTEND TIME Substantial Completion of Document Production and Fact Discovery Cutoff to March 16, 2016 and July 14, 2016, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 1/20/2016. (nms)
January 19, 2016	Filing 48 MEMORANDUM OPINION providing early claim construction of one term in U.S. Patent No. 8,389,007. Within five days the parties shall submit a proposed order consistent with this Memorandum Opinion suitable for submission to the jury. Signed by Judge Richard G. Andrews on 1/19/2016. (nms)
December 30, 2015	Filing 47 NOTICE OF SERVICE of (1) Purdue's Second Set of Requests for Production of Documents and Things filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
December 30, 2015	Filing 46 NOTICE OF SERVICE of (i) Second Set of Interrogatories; and (ii) Second Set of Requests for Production filed by Acura Pharmaceuticals Inc..(Farnan, Brian)
December 3, 2015	Filing 45 ORAL ORDER: It is ordered that counsel for plaintiff will email a copy of the Markman decision when issued to Judge Thynge. In addition, counsel will advise in either a joint or separate emails to Judge Thynge, within a week after the Markman opinion issues, their positions on mediation and any other relevant information they feel would be helpful for the Court to know in relation to negotiations/settlement. A copy of the emails should also be sent to Cathleen Kennedy, Judge Thynge's Judicial Administrator. Ordered by Judge Mary Pat Thynge on 12/3/15. (cak)
November 24, 2015	Minute Entry for proceedings held before Judge Richard G. Andrews - Markman Hearing held on 11/24/2015. (Court Reporter Valerie Gunning.) (ksr, )
November 23, 2015	ORAL ORDER: The Markman Hearing scheduled for 11/24/2015 will now commence at 9:30 a.m. in Courtroom 6A before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 11/23/2015. (ksr, )
November 20, 2015	Filing 44 REDACTED VERSION of #41 Appendix, Volume 2, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 34 part 1, #2 Exhibit 34 part 2, #3 Exhibit 34 part 3, #4 Exhibit 35, #5 Exhibit 36, #6 Exhibit 37, #7 Exhibit 38, #8 Exhibit 39 part 1, #9 Exhibit 39 part 2, #10 Exhibit 40, #11 Exhibit 41, #12 Exhibit 42, #13 Exhibit 43, #14 Exhibit 44, #15 Exhibit 45, #16 Exhibit 46, #17 Exhibit 47, #18 Exhibit 48, #19 Exhibit 49, #20 Exhibit 50, #21 Exhibit 51, #22 Exhibit 52, #23 Exhibit 53, #24 Exhibit 54 part 1, #25 Exhibit 54 part 2, #26 Exhibit 55, #27 Exhibit 56, #28 Exhibit 57, #29 Exhibit 58, #30 Exhibit 59)(Castellano, Jeffrey) Modified on 11/20/2015 (nms).
November 20, 2015	Filing 43 REDACTED VERSION of #40 Appendix, Volume 1, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 1 part 1, #2 Exhibit 1 part 2, #3 Exhibit 1 part 3, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19 part 1, #22 Exhibit 19 part 2, #23 Exhibit 20 part 1, #24 Exhibit 20 part 2, #25 Exhibit 20 part 3, #26 Exhibit 20 part 4, #27 Exhibit 20 part 5, #28 Exhibit 20 part 6 of 6, #29 Exhibit 21, #30 Exhibit 22, #31 Exhibit 23, #32 Exhibit 24, #33 Exhibit 25, #34 Exhibit 26 part 1, #35 Exhibit 26 part 2, #36 Exhibit 27, #37 Exhibit 28, #38 Exhibit 29, #39 Exhibit 30, #40 Exhibit 31, #41 Exhibit 32, #42 Exhibit 33)(Castellano, Jeffrey) Modified on 11/20/2015 (nms).
November 20, 2015	Filing 42 REDACTED VERSION of #39 Joint Claim Construction Brief, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey) Modified on 11/24/2015 (nms).
November 16, 2015	Filing 41 [SEALED] APPENDIX, Volume 2 of 2 re #39 Joint Claim Construction Brief, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 34 part 1, #2 Exhibit 34 part 2, #3 Exhibit 34 part 3, #4 Exhibit 35, #5 Exhibit 36, #6 Exhibit 37, #7 Exhibit 38, #8 Exhibit 39 part 1, #9 Exhibit 39 part 2, #10 Exhibit 40, #11 Exhibit 41, #12 Exhibit 42, #13 Exhibit 43, #14 Exhibit 44, #15 Exhibit 45, #16 Exhibit 46, #17 Exhibit 47, #18 Exhibit 48, #19 Exhibit 49, #20 Exhibit 50, #21 Exhibit 51, #22 Exhibit 52, #23 Exhibit 53, #24 Exhibit 54 part 1, #25 Exhibit 54 part 2, #26 Exhibit 55, #27 Exhibit 56, #28 Exhibit 57, #29 Exhibit 58, #30 Exhibit 59)(Castellano, Jeffrey) Modified on 11/17/2015 (nms).
November 16, 2015	CORRECTING ENTRY: The pdf for D.I. #39 has been replaced with an amended version per counsel's request. Formatting problems have been corrected. (nms)
November 16, 2015	CORRECTING ENTRY: Exhibits 34 through 59 have been removed from D.I. #40 , and will be refiled at a separate docket item number. (nms)
November 13, 2015	Filing 40 [SEALED] APPENDIX Volume 1 of 2 re #39 Joint Claim Construction Brief, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 1 part 1 of 3, #2 Exhibit 1 part 2 of 3, #3 Exhibit 1 part 3 of 3, #4 Exhibit 2, #5 Exhibit 3, #6 Exhibit 4, #7 Exhibit 5, #8 Exhibit 6, #9 Exhibit 7, #10 Exhibit 8, #11 Exhibit 9, #12 Exhibit 10, #13 Exhibit 11, #14 Exhibit 12, #15 Exhibit 13, #16 Exhibit 14, #17 Exhibit 15, #18 Exhibit 16, #19 Exhibit 17, #20 Exhibit 18, #21 Exhibit 19 part 1, #22 Exhibit 19 part 2, #23 Exhibit 20 part 1, #24 Exhibit 20 part 2, #25 Exhibit 20 part 3, #26 Exhibit 20 part 4 of 6, #27 Exhibit 20 part 5 of 6, #28 Exhibit 20 part 6, #29 Exhibit 21, #30 Exhibit 22, #31 Exhibit 23, #32 Exhibit 24, #33 Exhibit 25, #34 Exhibit 26 part 1, #35 Exhibit 26 part 2, #36 Exhibit 27, #37 Exhibit 28, #38 Exhibit 29, #39 Exhibit 30, #40 Exhibit 31, #41 Exhibit 32, #42 Exhibit 33)(Castellano, Jeffrey) Modified on 11/16/2015 (nms). Modified on 11/16/2015 (nms).
November 13, 2015	Filing 39 [SEALED] Joint Claim Construction Brief for the Term "Polyvinylpyrrolidone," filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey) Modified on 11/16/2015 (nms). (Main Document 39 replaced on 11/16/2015) (nms).
November 13, 2015	Filing 38 ORAL ORDER: The teleconference scheduled for Thursday, December 3, 2015 with Judge Thynge shall NOW TAKE PLACE AT 11:30 AM Eastern time to be initiated by counsel for the defendants. The purpose of the teleconference is to discuss the parties' position on future mediation. Ordered by Judge Mary Pat Thynge on 11/13/15. (cak) Modified on 11/13/2015 (cak).
November 4, 2015	Filing 37 STIPULATION TO EXTEND TIME to file the Joint Claim Construction Brief to 11/13/2015 - filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
November 4, 2015	SO ORDERED, re #37 STIPULATION TO EXTEND TIME to file the Joint Claim Construction Brief to 11/13/2015, filed by Egalet US Inc., Egalet Corporation, Acura Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 11/4/2015. (nms)
October 20, 2015	Filing 36 NOTICE OF SERVICE of (i) Defendants' Response to Purdue's First Set of Requests for Admission Regarding Claim Construction of Polyvinylpyrrolidone and (ii) Defendants' Responses to Purdue's First Set of Requests for Production of Documents and Things Regarding Claim Construction of Polyvinylpyrrolidone filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc..(Farnan, Brian)
September 28, 2015	Filing 35 NOTICE OF SERVICE of 1. Purdue's Responses and Objections to Defendants' First Set of Requests for Production Concerning Claim Construction of Polyvinylpyrrolidone; 2. Purdue's Responses to Defendants' First Set of Interrogatories Concerning Claim Construction of Polyvinylpyrrolidone; and 3. Purdue's Responses to Defendants' Request for Admissions Concerning Claim Construction of Polyvinylpyrrolidone filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
September 18, 2015	Filing 34 NOTICE OF SERVICE of 1. Purdue's First Set of Requests for Production of Documents and Things Regarding Claim Construction of Polyvinylpyrrolidone and 2. Purdue's First Set of Requests for Admission Regarding Claim Construction of Polyvinylpyrrolidone filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
September 15, 2015	Filing 33 NOTICE OF SERVICE of Defendants' Initial Paragraph 4(d) Disclosure filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc..(Farnan, Brian)
September 2, 2015	Filing 32 Joint Claim Construction Chart, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 1 part 1, #2 Exhibit 1 part 2, #3 Exhibit 1 part 3, #4 Exhibit 1 part 4, #5 Exhibit 2, #6 Exhibit 3, #7 Exhibit 4, #8 Exhibit 5, #9 Exhibit 6, #10 Exhibit 7, #11 Exhibit 8, #12 Exhibit 9, #13 Exhibit 10, #14 Exhibit 11, #15 Exhibit 12, #16 Exhibit 13, #17 Exhibit 14, #18 Exhibit 15, #19 Exhibit 16, #20 Exhibit 17, #21 Exhibit 18)(Shaw, John) Modified on 9/3/2015 (nms).
August 26, 2015	Filing 31 NOTICE OF SERVICE of (i) First Set of Interrogatories Concerning Claim Construction of "Polyvinylpyrrolidone"; (ii) First Set of Requests for Production Concerning Claim Construction of "Polyvinylpyrrolidone"; and (iii) First Set of Requests for Admissions Concerning Claim Construction of "Polyvinylpyrrolidone" filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc..(Farnan, Brian)
August 24, 2015	Filing 30 NOTICE OF SERVICE of Purdue's Initial Paragraph 4(c) Disclosures filed by Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
August 10, 2015	Filing 29 SO ORDERED Granting #28 Proposed Protective Order, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 8/10/2015. (nms)
August 10, 2015	Filing 28 PROPOSED Protective Order, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey) Modified on 8/10/2015 (nms).
August 10, 2015	Filing 27 ORAL ORDER: A teleconference is scheduled for Thursday, December 3, 2015 at 11:00 A.M. Eastern time to be initiated by counsel for the defendants. The purpose of the teleconference is to discuss the parties' position on future mediation. Issued by Judge Mary Pat Thynge on 8/10/15. (kjk)
August 10, 2015	Set Hearings: A Telephone Conference is set for 12/3/2015 at 11:00 AM in Chambers before Judge Mary Pat Thynge. (kjk)
July 27, 2015	Filing 26 STIPULATION TO EXTEND TIME (and proposed order) to submit proposed protective order to August 10, 2015 - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Fry, David)
July 27, 2015	Filing 25 ORAL ORDER: Pursuant to the teleconference of 7/24/15, counsel is to advise by the close of business Eastern time by Friday 8/7/15 whether mediation focused on resolving the matter is desired before the Markman Hearing on November 24, 2015. Signed by Judge Mary Pat Thynge on 7/27/15. (kjk)
July 27, 2015	SO ORDERED, re #26 STIPULATION TO EXTEND TIME and proposed order to submit proposed protective order to August 10, 2015, filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 7/27/2015. (nms)
July 23, 2015	Filing 24 NOTICE OF SERVICE of (1) Purdue's Initial Disclosures filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey)
July 23, 2015	Filing 23 NOTICE OF SERVICE of (i) Acura's Disclosure Pursuant to Paragraph 3 of the Default Standard for Discovery; (ii) Egalet's Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; and (iii) Defendants' Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Acura Pharmaceuticals Inc., Egalet Corporation.(Farnan, Brian)
July 17, 2015	Filing 22 ORAL ORDER: At the request of counsel the teleconference set for 7/21/15 at 1:00 p.m. is rescheduled for 7/24/2015 at 01:00 p.m. Eastern in Chambers before Judge Mary Pat Thynge. Counsel for the plaintiff shall initiate the call. Issued by Judge Mary Pat Thynge on 7/17/15. (kjk)
July 14, 2015	Filing 21 ORDER Setting Teleconference: Plaintiff's counsel to initiate the call. A Telephone Conference is set for 7/21/2015 at 12:00 NOON EASTERN TIME before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 7/14/15. (cak)
July 13, 2015	Filing 20 STIPULATION TO EXTEND TIME to submit Proposed Protective Order to 7/27/2015 - filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
July 13, 2015	SO ORDERED, re #20 STIPULATION TO EXTEND TIME to submit Proposed Protective Order to 7/27/2015 filed by Egalet US Inc., Egalet Corporation, Acura Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 7/13/2015. (nms)
July 1, 2015	Filing 19 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 11/16/2015. Amended Pleadings due by 11/16/2015. Fact Discovery due by 6/1/2016. Dispositive Motions due by 11/23/2016. Joint Claim Construction Brief due by 11/10/2015. A Markman Hearing is set for 11/24/2015, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A Pretrial Conference is set for 2/24/2017, at 8:30 AM in Courtroom 6A before Judge Richard G. Andrews. A five day Jury Trial is set for 3/6/2017, at 9:30 AM in Courtroom 6A before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/1/2015. (nms)
July 1, 2015	CASE REFERRED to Judge Thynge for Mediation. (cak)
June 30, 2015	Filing 18 PROPOSED Scheduling Order, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Letter)(Castellano, Jeffrey) Modified on 7/1/2015 (nms).
June 29, 2015	Filing 17 Official Transcript of Scheduling Conference held on 06-23-15 before Judge Richard G. Andrews. Court Reporter/Transcriber Leonard A. Dibbs. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 7/20/2015. Redacted Transcript Deadline set for 7/30/2015. Release of Transcript Restriction set for 9/28/2015. (lad)
June 23, 2015	Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 6/23/2015. Counsel for plaintiff will submit a revised order with agreed upon dates. (Court Reporter Leonard Dibbs.) (ksr, )
June 22, 2015	Filing 16 ANSWER to #11 Answer to Complaint, Counterclaim, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP.(Castellano, Jeffrey) Modified on 6/23/2015 (nms).
June 19, 2015	Filing 15 PROPOSED Scheduling Order, by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Letter)(Castellano, Jeffrey) Modified on 6/22/2015 (nms).
June 16, 2015	Filing 14 ORAL ORDER: Due to a scheduling conflict the Rule 16(b) Conference set for 6/18/2015, is CANCELED, and the conference will now be held on 6/23/2015, at 11:00 AM before Judge Richard G. Andrews. Ordered by Judge Richard G. Andrews on 6/16/2015. (nms)
June 3, 2015	Filing 13 Order Setting Rule 16(b) Conference: A Scheduling Conference is set for 6/18/2015, at 11:30 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 6/3/2015. (nms)
June 2, 2015	Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Egalet Corporation for Egalet US Inc. filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
May 29, 2015	Pro Hac Vice Attorney Morgan Chu,Gary N. Frischling,Yite John Lu for Acura Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (klc)
May 27, 2015	Filing 11 ANSWER to #1 Complaint, COUNTERCLAIM against PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP by Egalet US Inc., Acura Pharmaceuticals Inc., Egalet Corporation.(Farnan, Brian) Modified on 5/28/2015 (nms).
May 27, 2015	SO ORDERED, re #10 MOTION for Pro Hac Vice Appearance of Attorney Morgan Chu, Gary Frischling, and Y. John Lu filed by Egalet US Inc., Egalet Corporation, Acura Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 5/27/2015. (nms)
May 26, 2015	Filing 10 MOTION for Pro Hac Vice Appearance of Attorney Morgan Chu, Gary Frischling, and Y. John Lu - filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
April 28, 2015	Filing 9 STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise plead in response to the Complaint to 5/29/2015 - filed by Acura Pharmaceuticals Inc., Egalet Corporation, Egalet US Inc.. (Farnan, Brian)
April 28, 2015	SO ORDERED, re #9 STIPULATION TO EXTEND TIME for Defendants to move, answer or otherwise plead in response to the Complaint to 5/29/2015, filed by Egalet US Inc., Egalet Corporation, Acura Pharmaceuticals Inc. (Reset Answer Deadlines: Acura Pharmaceuticals Inc. answer due 5/29/2015; Egalet Corporation answer due 5/29/2015; Egalet US Inc. answer due 5/29/2015). Signed by Judge Richard G. Andrews on 4/28/2015. (nms)
April 16, 2015	Pro Hac Vice Attorney James F. Hibey,John L. Abramic,Katherine H. Johnson for Purdue Pharma LP added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
April 14, 2015	Filing 8 SUMMONS Returned Executed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Acura Pharmaceuticals Inc. served on 4/8/2015, answer due 4/29/2015. (Castellano, Jeffrey)
April 13, 2015	SO ORDERED, re #7 MOTION for Pro Hac Vice Appearance of Attorney John L. Abramic, Katherine H. Johnson, and James F. Hibey filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Signed by Judge Richard G. Andrews on 4/13/2015. (nms)
April 10, 2015	Filing 7 MOTION for Pro Hac Vice Appearance of Attorney John L. Abramic, Katherine H. Johnson, and James F. Hibey - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Castellano, Jeffrey)
April 8, 2015	Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (bkb)
April 7, 2015	Filing 6 SUMMONS Returned Executed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Egalet US Inc. served on 4/7/2015, answer due 4/28/2015. (Castellano, Jeffrey)
April 7, 2015	Filing 5 SUMMONS Returned Executed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. Egalet Corporation served on 4/7/2015, answer due 4/28/2015. (Castellano, Jeffrey)
April 6, 2015	Summons Issued with Magistrate Consent Notice attached as to All Defendants. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (aah)
April 3, 2015	Filing 4 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (aah)
April 3, 2015	Filing 3 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pharmaceutical Research Associates Inc. for PF Laboratories Inc.; Other Affiliate Purdue Pharma L.P. for Purdue Pharmaceuticals LP; Other Affiliate Purdue Holdings L.P. for Purdue Pharma LP filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (aah)
April 3, 2015	Filing 2 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,389,007 B2; (aah)
April 3, 2015	Filing 1 COMPLAINT filed with Jury Demand against All Defendants - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-1702144.) - filed by PF Laboratories Inc., Purdue Pharma LP, Purdue Pharmaceuticals LP. (Attachments: #1 Exhibit 1-4, #2 Exhibit 2-4, #3 Exhibit 3-4, #4 Exhibit 4-4, #5 Civil Cover Sheet)(aah)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Purdue Pharma L.P. et al v. Acura Pharmaceuticals Inc. et al
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Web	[ Unicourt \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: PF Laboratories Inc.
Represented By:	John W. Shaw
Represented By:	David M. Fry
Represented By:	Jeff Castellano
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: Purdue Pharma LP
Represented By:	John W. Shaw
Represented By:	David M. Fry
Represented By:	James F. Hibey
Represented By:	Jeff Castellano
Represented By:	John L. Abramic
Represented By:	Katherine H. Tellez
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Plaintiff: Purdue Pharmaceuticals LP
Represented By:	John W. Shaw
Represented By:	David M. Fry
Represented By:	Jeff Castellano
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Acura Pharmaceuticals Inc.
Represented By:	Brian E. Farnan
Represented By:	Gary N. Frischling
Represented By:	Morgan Chu
Represented By:	Yite John Lu
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Egalet Corporation
Represented By:	Brian E. Farnan
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]
Defendant: Egalet US Inc.
Represented By:	Brian E. Farnan
Search News	[ Google News \| Marketwatch \| Wall Street Journal \| Financial Times \| New York Times ]
Search Finance	[ Google Finance \| Yahoo Finance \| Hoovers \| SEC Edgar Filings ]
Search Web	[ Unicourt \| Justia Dockets \| Legal Web \| Google \| Bing \| Yahoo \| Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?